SECOR Capital Advisors, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 172 filers reported holding HAEMONETICS CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2018$7,214,000
+83.0%
80,437
+49.3%
0.62%
+90.7%
Q1 2018$3,943,000
+80.4%
53,894
-10.7%
0.32%
+35.6%
Q3 2016$2,186,000
+55.6%
60,371
+24.5%
0.24%
+35.0%
Q2 2016$1,405,000
+107.8%
48,479
+131.3%
0.18%
-7.3%
Q4 2015$676,000
+85.2%
20,958
+100.4%
0.19%
-7.7%
Q3 2014$365,00010,4600.21%
Other shareholders
HAEMONETICS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders